IL136025A0 - Combination therapy for the treatment of migraine - Google Patents

Combination therapy for the treatment of migraine

Info

Publication number
IL136025A0
IL136025A0 IL13602500A IL13602500A IL136025A0 IL 136025 A0 IL136025 A0 IL 136025A0 IL 13602500 A IL13602500 A IL 13602500A IL 13602500 A IL13602500 A IL 13602500A IL 136025 A0 IL136025 A0 IL 136025A0
Authority
IL
Israel
Prior art keywords
migraine
treatment
combination therapy
therapy
combination
Prior art date
Application number
IL13602500A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL136025A0 publication Critical patent/IL136025A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13602500A 1999-05-14 2000-05-08 Combination therapy for the treatment of migraine IL136025A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13431299P 1999-05-14 1999-05-14

Publications (1)

Publication Number Publication Date
IL136025A0 true IL136025A0 (en) 2001-05-20

Family

ID=22462780

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13602500A IL136025A0 (en) 1999-05-14 2000-05-08 Combination therapy for the treatment of migraine

Country Status (11)

Country Link
US (1) US20050101653A1 (ja)
EP (1) EP1051995A3 (ja)
JP (1) JP2000344667A (ja)
KR (1) KR20010029716A (ja)
AU (1) AU3406500A (ja)
CA (1) CA2308826A1 (ja)
CO (1) CO5261541A1 (ja)
HU (1) HUP0001891A3 (ja)
IL (1) IL136025A0 (ja)
PE (1) PE20010128A1 (ja)
ZA (1) ZA200002338B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
DE69922688T2 (de) 1998-11-02 2005-12-01 Merck & Co. Inc. Zusammensetzungen aus einem 5ht1b/1d agonisten und einem selektiven cox-2 hemmer zur behandlung von migräne
GB9929039D0 (en) * 1999-12-08 2000-02-02 Glaxo Group Ltd Medicaments
EP1575566B1 (en) 2002-12-26 2012-02-22 Pozen, Inc. Multilayer dosage forms containing naproxen and triptans
MXPA05010070A (es) * 2003-04-11 2005-11-23 Pfizer Combinacion farmaceutica.
CN102088966B (zh) 2008-06-20 2015-06-10 阿尔法制药有限公司 药物制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5286843A (en) * 1992-05-22 1994-02-15 Rohm And Haas Company Process for improving water-whitening resistance of pressure sensitive adhesives
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
KR100229343B1 (ko) * 1993-11-30 1999-11-01 윌리암스 로저 에이 염증치료용 치환 피라졸일벤젠술폰아미드
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US5691374A (en) * 1995-05-18 1997-11-25 Merck Frosst Canada Inc. Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
US5861419A (en) * 1996-07-18 1999-01-19 Merck Frosst Canad, Inc. Substituted pyridines as selective cyclooxygenase-2 inhibitors
US5872145A (en) * 1996-08-16 1999-02-16 Pozen, Inc. Formulation of 5-HT agonist and NSAID for treatment of migraine
US6077850A (en) * 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
US5994379A (en) * 1998-02-13 1999-11-30 Merck Frosst Canada, Inc. Bisaryl COX-2 inhibiting compounds, compositions and methods of use

Also Published As

Publication number Publication date
CO5261541A1 (es) 2003-03-31
HUP0001891A3 (en) 2003-07-28
AU3406500A (en) 2000-11-16
EP1051995A3 (en) 2003-01-08
HU0001891D0 (en) 2000-07-28
EP1051995A2 (en) 2000-11-15
US20050101653A1 (en) 2005-05-12
ZA200002338B (en) 2001-11-12
JP2000344667A (ja) 2000-12-12
KR20010029716A (ko) 2001-04-16
CA2308826A1 (en) 2000-11-14
HUP0001891A2 (en) 2001-03-28
PE20010128A1 (es) 2001-02-28

Similar Documents

Publication Publication Date Title
EP1446012A4 (en) Bacteriolytic combination therapy for the treatment of tumors
HK1047284A1 (en) 2-amino-benzoxazinone derivatives for the treatment of obesity
IL164599A0 (en) Combination therapy for the treatment of cancer
IL158329A0 (en) Antiangiogenic combination therapy for the treatment of cancer
EP1077704A4 (en) COMBINATION THERAPY FOR TREATING DEPRESSION
HUP0500424A2 (en) Combination therapy for the treatment of cancer
IL136960A0 (en) Combination therapy for the treatment of migraine
IL146697A0 (en) SELECTIVE iGluR5 RECEPTOR FOR THE TREATMENT OF MIGRAINE
HK1040184A1 (zh) 治療青光眼之組合療法
HK1047048A1 (en) Therapeutic use of melatonin.
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
AU2001285156A1 (en) Combination therapy for the treatment of migraine
IL136025A0 (en) Combination therapy for the treatment of migraine
IL136962A0 (en) Combination therapy for the treatment of migraine
IL136024A0 (en) Combination therapy for the treatment of migraine
IL135994A0 (en) Combination therapy for the treatment of aids
GB2363604B (en) S-nitrosothiols as agents for the treatment of circulatory dsyfunctions
PT1451177E (pt) Derivados substituídos de 2-pirrolidin-2-1l-1h-indole para o tratamento da enxaqueca.
GB9819590D0 (en) Combination therapy for the treatment of aids
GB9807938D0 (en) Combination therapy for the treatment of AIDS
GB9924980D0 (en) Therapeutic treatment
GB9901505D0 (en) Therapeutic treatment
ZA9810306B (en) Combination therapy for the treatment of aids
GB9901310D0 (en) Methods of treatment
GB9917181D0 (en) Methods of treatment